CommercialPrior AuthMedium impact
Pharmacy Program Updates: Prior Authorization Changes Effective May 1, 2026
BCBS Illinois·IL · Neurology, Endocrinology, Pulmonology +3 more·Prior Authorization
Effective date
May 1, 2026
We identified it
Jun 16, 2026
Summary
Blue Cross Blue Shield of Illinois is updating prior authorization criteria for several pharmacy programs effective May 1, 2026, including changes to Duvyzat, Multiple Sclerosis medications, Ohtuvayre, and Urea Cycle Disorders treatments. Additional therapeutic alternatives will be added to prior authorization requirements starting July 1, 2026.
Action Required
By April 30, 2026: Clinical staff must review updated prior authorization criteria for Duvyzat, Multiple Sclerosis medications, Ohtuvayre, and Urea Cycle Disorders treatments. Update EMR templates to reflect new PA requirements. Before July 1, 2026: Review and implement additional therapeutic alternatives PA requirements. Monitor BCBSIL website for detailed PA request forms and updated drug lists to ensure proper authorization processes.